Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$28.86 -0.79 (-2.66%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Return on Equity [ROE] (2016 - 2026)

Updated

Lakefront Biotherapeutics' Return on Equity [ROE] came in at 9866.49% for the quarter ended Mar 31, 2026, up 9872.48 percentage points from -5.99% a year earlier but down 1406.31 percentage points from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Return on Equity [ROE] (2016 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Lakefront Biotherapeutics' Return on Equity [ROE] was 10676.41%, up 10673.80 percentage points from the prior year.

  • Return on Equity [ROE] carries a five-year change of +10687.61 percentage points (years ended Dec 2020 to Dec 2025).
  • Going back by year, Return on Equity [ROE] was 2.61% in the year ended Dec 31, 2024 (-5.42 pp), 8.03% in the year ended Dec 31, 2023 (+15.97 pp), -7.94% in the year ended Dec 31, 2022 (-3.98 pp) and -3.96% in the year ended Dec 31, 2021 (+7.24 pp).
  • The five-year range for quarterly Return on Equity [ROE] is -16.75% (the quarter ended Sep 30, 2025) to 11272.80% (the quarter ended Dec 31, 2025).
  • Year-over-year, Return on Equity [ROE] increased in two of the last four quarters, with an average year-over-year change of +5280.43 percentage points.
  • Business Quant data shows LKFT's Return on Equity [ROE] at 11272.80% (quarter ended Dec 31, 2025), -16.75% (quarter ended Sep 30, 2025) and -9.46% (quarter ended Jun 30, 2025) in the three quarters before the quarter ended Mar 31, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Lakefront Biotherapeutics 1.95 Bn 1.95 Bn 3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 9,866.49%
Dec 31, 2025 11,272.80%
Sep 30, 2025 -16.75%
Jun 30, 2025 -9.46%
Mar 31, 2025 -5.99%
Dec 31, 2024 2.56%
Mar 31, 2024 9.79%
Dec 31, 2023 7.78%
Mar 31, 2023 -6.94%
Mar 31, 2022 -7.16%
Jun 30, 2020 2.96%
Mar 31, 2020 5.23%
Dec 31, 2019 5.52%
Sep 30, 2019 15.13%
Jun 30, 2019 -5.65%
Mar 31, 2019 -4.81%
Dec 31, 2018 -4.03%
Sep 30, 2018 -0.01%
Jun 30, 2018 -0.03%
Mar 31, 2018 -14.19%
API Access

Lakefront Biotherapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LKFT&period=max&api_key=YOUR_API_KEY